Term: bevacizumab
IPA: ˌbɛv.əˈsɪz.ʊˌmæb

==English==
{{wp}}

===Etymology===
From {{af|en|beva-|-ci-|-zumab|qq1=of unknown origin|t2=cardiovascular|t3=humanized monoclonal antibody}}.

{{rfe|en}}

===Pronunciation===
* {{IPA|en|/ˌbɛv.əˈsɪz.ʊˌmæb/|a=GA}}

===Noun===
{{en-noun|-}}

# {{lb|en|pharmaceutical drug}} An [[anticancer]] drug that is a [[genetically engineered]] [[monoclonal antibody]] administered [[intravenously]] to slow or inhibit tumor growth especially in some [[metastatic]] forms of cancer (such as {{w|colorectal cancer}